Author: Keizer Ron J. Huitema Alwin D.R. Schellens Jan H.M. Beijnen Jos H.
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.49, Iss.8, 2010-08, pp. : 493-507
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
By Dirks Nathanael L. Meibohm Bernd
Clinical Pharmacokinetics, Vol. 49, Iss. 10, 2010-10 ,pp. :
Pharmacogenetics and pharmacogenomics of therapeutic monoclonal antibodies
Pharmacogenomics, Vol. 7, Iss. 7, 2006-10 ,pp. :
Pharmacokinetics of Biotech Drugs: Peptides, Proteins and Monoclonal Antibodies
Current Drug Metabolism, Vol. 10, Iss. 7, 2009-09 ,pp. :
Therapeutic Monoclonal Antibodies and Multiple Sclerosis: The Essentials
Medicinal Chemistry, Vol. 14, Iss. 2, 2018-02 ,pp. :